RxDoctor Payments Data

Michael Erossy

Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1255821625

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.5%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Zimmer Biomet at 42.0% of the total. Reporting peaked in 2024 at $13,659 and has fallen 79.5% since, to $2,804 in 2025.

$21,573in general payments, 2019–2025

Across 122 payments — averaging $176.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$9K
  • Smith+Nephew$5K
  • Stryker$4K
  • Medical Device Business Services, Inc.$2K
  • Heron Therapeutics, Inc.$241
  • Davol Inc.$158
  • plus $693 from 6 others

What the payments were for

  • Grants$2,50012%
  • Travel & lodging$7,40634%
  • Food & beverage$9,16742%
  • Education$2,50012%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,573 in reported general payments places this provider in the 60th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$71,659
Medicare patients
256
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam30$102
Mupirocin13$83

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →